Showing results (1361-1370 of 5,535) with videos related to
Sort By:
Pageof 554
Inflammatory Bowel Diseases|November 5, 2026
The application of an artificial intelligence-enhanced virtual reality cognitive behavioral therapy tool is feasible and acceptable in patients with inflammatory bowel disease: A multicenter mixed methods pilot studyAlvin T George, Alexandra R McDermott, Alyse R Bedell, et al.Inflammatory Bowel Diseases|June 1, 2001
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot studyB E Sands, W J Tremaine, W J Sandborn, et al.Inflammatory Bowel Diseases|August 23, 2001
Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's diseaseW J Sandborn, E V Loftus, J F Colombel, et al.Inflammatory Bowel Diseases|August 23, 2001
Glucocorticoid receptor mRNA in patients with ulcerative colitis: a study of responders and nonresponders to glucocorticosteroid therapyL Flood, R Löfberg, P Stierna, et al.Inflammatory Bowel Diseases|August 23, 2001
Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel diseaseI C Lawrance, L Maxwell, W DoeInflammatory Bowel Diseases|August 23, 2001
Colonoscopic findings in intestinal Behçet's diseaseC R Lee, W H Kim, Y S Cho, et al.Inflammatory Bowel Diseases|November 28, 2002
Using a genome-wide scan and meta-analysis to identify a novel IBD locus and confirm previously identified IBD lociC Noel Williams, Kerry Kocher, Eric S Lander, et al.Inflammatory Bowel Diseases|November 28, 2002
Normal Breast Milk Limits the Development of Colitis in IL-10-Deficient MiceKaren L Madsen, Richard N Fedorak, Michele M Tavernini, et al.Inflammatory Bowel Diseases|December 14, 2002
Response of refractory colitis to intravenous or oral tacrolimus (FK506)Klaus Fellermann, Zita Tanko, Klaus R Herrlinger, et al.Pageof 554